March 17, 2018 9:19 PM ET


Company Overview of Reven Pharmaceuticals, Inc.

Company Overview

Reven Pharmaceuticals, Inc. researches, develops, and manufactures products for the treatment of vascular diseases. The company offers products for treatment of critical limb ischemia, peripheral arterial, coronary artery, endothelial dysfunction, and acute ischemic stroke. Its product include Rejuveinix, a pharmaceutical product that removes plaque and reverse the underlying disease state that results in the creation of arterial plaque. Reven Pharmaceuticals, Inc. was formerly known as Noventis, Inc. Reven Pharmaceuticals, Inc. was founded in 1999 and is based in Golden, Colorado.

600 Corporate Circle

Suite D

Golden, CO 80401

United States

Founded in 1999



Key Executives for Reven Pharmaceuticals, Inc.

Chief Executive Officer and Director
President, COO and Director
Chief Technology Officer
Chief Administrative Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Reven Pharmaceuticals, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at